112 results
424B4
TENX
Tenax Therapeutics Inc
9 Feb 24
Prospectus supplement with pricing info
5:00pm
in 6-minute walk distance over 12 weeks or a single Phase 3 trial with clinical worsening (e.g., death, hospitalization for heart failure, or decline
424B3
0arxm5ge1wt4b
15 Aug 23
Prospectus supplement
4:28pm
8-K
EX-3.1
aus1ho
15 Aug 23
Amendments to Articles of Incorporation or Bylaws
4:05pm
424B3
oxbnvz8p
13 Apr 23
Prospectus supplement
5:00pm
8-K
EX-99.1
tdjuyk13pwprk
13 Apr 23
Tenax Therapeutics Provides 2023 Business Update
9:00am
424B3
o6hsor2 1mprav
4 Apr 23
Prospectus supplement
4:30pm
8-K
EX-10.2
9o33j fsn
10 Jun 22
Departure of Directors or Certain Officers
4:31pm
8-K
EX-10.1
n43ah8
10 Jun 22
Departure of Directors or Certain Officers
4:31pm
8-K
EX-99.1
3hy0uue8haad9
24 Jan 22
TENAX THERAPEUTICS January 2022 I Corporate Presentation www.tenaxthera.com NASDAQ TENX
4:16pm